In the last trading session, 1.62 million IN8bio Inc (NASDAQ:INAB) shares changed hands as the company’s beta touched 0.03. With the company’s per share price at $0.27 changed hands at $0.0 or 0.15% during last session, the market valuation stood at $19.71M. INAB’s last price was a discount, traded about -544.44% off its 52-week high of $1.74. The share price had its 52-week low at $0.22, which suggests the last value was 18.52% up since then.
Analysts gave the IN8bio Inc (INAB) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended INAB as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. IN8bio Inc’s EPS for the current quarter is expected to be -0.08.
IN8bio Inc (NASDAQ:INAB) trade information
Instantly INAB was in green as seen at the end of in last trading. With action -6.50%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 5.72%, with the 5-day performance at -6.50% in the red. However, in the 30-day time frame, IN8bio Inc (NASDAQ:INAB) is -5.20% down.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -50.62%. The 2025 estimates are for IN8bio Inc earnings to increase by 43.67%, but the outlook for the next 5-year period is at 32.08% per year.
INAB Dividends
IN8bio Inc is expected to release its next quarterly earnings report in March.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 3.2892% or 1.42 million shares worth $1.21 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . With 952.49 shares estimated at $0.26 million under it, the former controlled 1.31% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.65% of the shares, roughly 471.41 shares worth around $0.13 million.
